178 results
8-K
EX-10.1
OGEN
Oragenics Inc
29 Dec 23
Completion of Acquisition or Disposition of Assets
7:30am
10-Q
2023 Q2
EX-10.6
OGEN
Oragenics Inc
Quarterly report
11 Aug 23
4:16pm
8-K
EX-10.1
OGEN
Oragenics Inc
10 Aug 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
OGEN
Oragenics Inc
7 Aug 23
Oragenics, Inc. Announces Private Placement
8:09am
10-Q
2023 Q1
EX-10.5
OGEN
Oragenics Inc
Quarterly report
12 May 23
4:51pm
8-K
EX-10.1
fc37gt65
8 Mar 23
Oragenics Appoints Janet Huffman as Chief Financial Officer
9:22am
8-K
EX-10.1
wzsod0bppgo wrql
23 Jun 22
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
5:22pm
8-K
EX-10.1
1t3ncyp6
28 Feb 22
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-10.2
rurqy2iv
28 Feb 22
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-10.4
5t7c4
28 Feb 22
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-10.3
49e5illajh5ex4z7b7
28 Feb 22
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-10.1
9c0i5qbny
28 Dec 20
Oragenics, Inc. Announces $6.5 Million Registered Direct Offering
5:04pm
8-K
EX-10.3
3mrkuqv hawinz
5 Jun 20
Entry into a Material Definitive Agreement
4:00pm